CONTACT
Group Companies
MEDIA STORIES
10-July-2022
Biocon Biologics’ antibody drug unit in Bengaluru gets EU GMP certificate
06-July-2022
Biocon Biologics receives EU GMP certification for its new biologics manufacturing facility in Bengaluru
05-July-2022
Biocon Biologics expects big gains from integration of Viatris business, SII deal
09-June-2022
Expect regulatory nods for deal with Serum and Viatris to come by H2: Kiran Mazumdar-Shaw, chairperson, Biocon and Biocon Biologics
04-May-2022
Biocon Biologics may close $3.34 billion Viatris deal in Q1
02-May-2022
Eyeing over 15% market share in US for insulin Glargine: Shreehas Tambe
30-April-2022
Biocon Biologics expects R&D expenses to hover between 10-15% in the next financial year
29-April-2022
Biocon arm to buy US company Biosimilar biz for $3.34 billion
01-Mar-2022
Biocon Biologics acquires Viatris for $3.33 billion
01-Mar-2022
Biocon Biologics acquires Viatris’ biosimilars business in $3.3 bn deal
28-Feb-2022
R&D expenditure will rise in the coming quarters: Biocon Biologics MD
25-Jan-2022
Insulins access program for young expanded in Dec quarter: Biocon Biologics MD
24-Jan-2022
Biocon Biologics set to reap biosimilar insulin glargine opportunity in US
22-Jan-2022
The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon’s diabetes drug
25-Nov-2021
Biocon Biologics, Viatris confirm offering steep savings on long-acting insulin through Walgreens Prescription Savings Club
19-Nov-2021
Walgreens to sell Biocon’s insulin Semglee in the U.S.
19-Nov-2021
Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
16-Nov-2021
Biocon starts campaign to treat diabetic children, train healthcare workers
15-Nov-2021
Access to diabetes care: If not now, then when?
14-Nov-2021
Biocon Rating: Hold – Vaccines to complement biosimilar portfolio
20-Sep-2021
Biocon Biologics, Serum Institute Life Sciences announce strategic alliance
20-Sep-2021
Biocon jumps into vaccines through $4.9bn Serum Institute pact
20-Sep-2021
Can Serum deal provide a booster dose to Biocon’s target price?
20-Sep-2021
Interchangeable insulin to help us compete with big insulin makers: Kiran Mazumdar-Shaw
29-Aug-2021
Vaccines alone will not protect and make the world safer: Biocon chief
30-Jul-2021
India must use, share Covid data transparently: Kiran Mazumdar-Shaw
26-Jul-2021